New particles aim to shrink fibroids without surgery

NCT ID NCT06153667

Recruiting now Disease control Sponsor: Merit Medical Systems, Inc. Source: ClinicalTrials.gov ↗

First seen Apr 02, 2026 · Last updated May 15, 2026 · Updated 8 times

Summary

This study is testing Bearing nsPVA particles, which are injected to block blood flow to uterine fibroids, shrinking them and easing symptoms like pain and heavy bleeding. About 100 women with symptomatic fibroids will be followed for 6 months to see if symptoms improve by at least half. The goal is to confirm the particles are safe and effective for controlling fibroids.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Alfred Health
RECRUITING

Sydney, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Astra Vascular/Astra Vein Treatment Center
RECRUITING

Brooklyn, New York, 11234, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
Royal Gwent Hospital (Aneurin Bevan UHB)
RECRUITING

Newport, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact
The Wesley Hospital
RECRUITING

Brisbane, Australia

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

UTERINE FIBROID